Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
批准号:
8553845
负责人:
Tomoshige Kino
金额:
$19.97万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
2 year oldAdenosineAdrenal GlandsAgingAnimalsAnorexia NervosaApoptosisAutoimmune ProcessBiologicalBiological RhythmBiologyCardiovascular systemCellsCircadian RhythmsComputersCorticotropin-Releasing HormoneDevelopmentDiseaseEstrogensExerciseFailureFertilityFunctional disorderGenesGlucocorticoidsGrowthHomeostasisHormonesHumanHyperactive behaviorHypothalamic structureInfertilityLuteinizing HormoneMalnutritionMenopauseMental DepressionMessenger RNAMetabolicMicroRNAsMoodsMusNeuraxisNutritionalOocytesOralOrganOvarianOvarian FollicleOvaryOvulationPathologicPathway interactionsPatientsPeriodicityPeripheralPhasePhysiologicalPhysiological ProcessesPhysiologyPituitary GlandPregnancyProductionProgestinsProtein KinaseProteinsProteomicsRNARegulationReportingReproductionResourcesRoleSleeplessnessSteroid biosynthesisStressSystemTissuesUntranslated RNAage relatedagedantalarminbaseclinical applicationgranulosa cellhuman studyinhibitor/antagonistmRNA Expressionpreclinical studyprotein expressionreceptorresearch studysteroid hormonetranscription factoruptakeweb site
中文摘要
我们已经证明,几种人类状态的特征是中枢应激系统的多动或低动,这不仅解释了情绪变化,也解释了患有这种疾病的患者发展发育、代谢、心血管或自身免疫性并发症的倾向。我们完成了新发现的非肽口服CRH 1型受体拮抗剂安他拉明的临床前研究,表明这种拮抗剂可能对大量以应激系统亢进为特征的状态有用,如抑郁症、神经性厌食症和特发性失眠。
英文摘要
We have demonstrated that several human states are characterized by hyperactivity or hypoactivity of the central stress system, which explains not only mood changes but also the propensity of patients with such disorders to develop developmental, metabolic, cardiovascular or autoimmune complications. We completed preclinical studies with the newly discovered nonpeptide, oral, CRH type 1 receptor antagonist, antalarmin, which show that such an antagonist may be useful in a large number of states characterized by hyperactivity of the stress system, such as depression, anorexia nervosa and idiopathic insomnia.
We also found that the noncoding (nc) RNA growth arrest-specific 5 (Gas5), which accumulates in growth-arrested cells, but whose physiologic roles are not known as yet, and the adenosine 5' monophosphate-activated protein kinase (AMPK), a master regulator of energy homeostasis, sensing energy depletion inside the body and stimulating pathways that increase fuel uptake and save on peripheral supplies, regulated transcriptional activity of the GR. The former accomplished this by acting as a decoy RNA GRE, the latter by phosphorylating the GR. These results indicate that the biologic actions of HPA axis are regulated at the level of target tissues by the nutritional state and availability of energy resources, subsequently influencing the action of HPG axis.
We have previously reported that CLOCK/BMAL1, the self-oscillating transcription factors that generate circadian rhythms both in the central nervous system and periphery, rhythmically repressed GR-induced transcriptional activity, indicating that CLOCK/BMAL1 functions as a reverse phase negative regulator of glucocorticoid action in target tissues, possibly by antagonizing the biologic actions of diurnally fluctuating circulating glucocorticoids. We performed one human study and revealed that this negative regulation on GR transcriptional activity by CLOCK was also functional in humans. As an extension of this circadian rhythm project, we have screened the microRNAs regulated in a circadian fashion in granulosa cells of mouse ovaries. MicroRNAs are short hairpin-like RNAs that demonstrate strong biological actions on reproduction, and specifically, granulosa cells by influencing proliferation and apoptosis, as well as steroidogenesis of these cells. Granulosa cells, on the other hand, are components of ovarian follicles required for proper development of oocytes and steroid hormone production. We have found that primary granulosa cells obtained from mouse ovaries were in circadian oscillation of several CLOCK-related genes, such as Per1/2 and Cry1/2. Using total RNAs purified from these cells and the array plates containing 600 known microRNAs, we found that 10% of the miRNAs examined was under circadian fluctuation among which miR196a showed the most significant changes. In computer/website-based search, mRNA/protein expression of several Hox genes may be regulated by this miRNA. Among them, mRNA expression of the HoxA5, a transcription factor expressed in the granulosa cells with known activity to support their responsiveness to the luteinizing hormone, was in typical circadian rhythmicity. We are now performing several lines of experiments to examine impact of miR196a and its circadian rhythms on granulosa cell activities by focusing on HoxA5.
Aging is an important factor for reducing the chance of successful pregnancy, eventually developing ovarian failure and menopause with virtually no production of estrogens and progestins, but the biological mechanisms underlying this physiologic process have not been elucidated completely as yet. It is also possible that pathologic infertility, such as by malnutrition, stress and exercise, might share part of the mechanisms responsible for aging-dependent ovarian failure. To examine impact of aging on ovarian functions, we again examined microRNA expression in primary granulosa cells obtained from mouse ovaries: We obtained granulosa cells from 2-year old mice, and examined their expression of 600 microRNAs by employing the cells of young mice (6-9 week old) as controls. We identified that expression of miR503 and miR322, which are among the most highly expressed miRNAs in young ovaries, was significantly down regulated in aged granulosa cells (by over 90% reduction). We are now examining target protein of these miRNAs by using the proteomic analysis. We are now preparing one animal study in which we knockdown these miRNAs in mice using chemically modified miRNA inhibitors to examine their roles on ovulation and fertility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mediators and Regulators of Glucocorticoid Actions
-
批准号:8351165
-
项目类别:
-
资助金额:$160.15万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators and Regulators of Glucocorticoid Actions
-
批准号:7734762
-
项目类别:
-
资助金额:$28.88万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators/Regulators of Glucocorticoid Actions
-
批准号:7209191
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators and Regulators of Glucocorticoid Act
-
批准号:7332773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
-
批准号:8941436
-
项目类别:
-
资助金额:$16.1万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
-
批准号:7734695
-
项目类别:
-
资助金额:$28.87万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators and Regulators of Glucocorticoid Actions
-
批准号:8941482
-
项目类别:
-
资助金额:$48.31万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Endocrine-immune-reproductive System Interactions
-
批准号:8941435
-
项目类别:
-
资助金额:$16.1万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Endocrine-immune-reproductive System Interactions
-
批准号:7968513
-
项目类别:
-
资助金额:$46.5万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators and Regulators of Glucocorticoid Actions
-
批准号:7968640
-
项目类别:
-
资助金额:$46.5万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
-
批准号:8351107
-
项目类别:
-
资助金额:$53.38万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Endocrine-immune-reproductive System Interactions
-
批准号:8736815
-
项目类别:
-
资助金额:$17.47万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Endocrine-immune-reproductive System Interactions
-
批准号:8553844
-
项目类别:
-
资助金额:$19.97万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
-
批准号:8736816
-
项目类别:
-
资助金额:$17.47万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators and Regulators of Glucocorticoid Act
-
批准号:6993547
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Endocrine-immune-reproductive System Interactions
-
批准号:8351106
-
项目类别:
-
资助金额:$53.38万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators and Regulators of Glucocorticoid Actions
-
批准号:7594207
-
项目类别:
-
资助金额:$22.23万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Molecular Mediators and Regulators of Glucocorticoid Actions
-
批准号:8553900
-
项目类别:
-
资助金额:$59.92万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Endocrine-immune-reproductive System Interactions
-
批准号:8149240
-
项目类别:
-
资助金额:$45.56万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
Pathophysiology of The Hypothalamic-pituitary-adrenal & Gonadal Axes
-
批准号:8149241
-
项目类别:
-
资助金额:$45.56万
-
财政年份:--
-
负责人:Tomoshige Kino
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: